Wells Fargo analyst Larry Biegelsen upgraded Novocure to Overweight from Equal Weight with a price target of $89, up from $74.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on NVCR: